BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
ERBB2
,
Apoptosis
,
Leukemia
,
Intestine
,
Holistic medicine
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TEMO
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Skeletal muscle
Eosinophil of peripheral blood
Dendritic (plasmacytoid) cell
Basophil of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Muscle cachexia
Dehydration
Effects of heat
Disorder related to transplantation
Hemoglobinopathy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Piromidic Acid
Lymecycline
Iodipamide
dironyl
Timolol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-1-3p
DEAF1
HBB
GUCY1A1
HNRNPA0
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Proteasome-Associated Proteins, PA200 and ECPAS, Are Essential for Murine Spermatogenesis.
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antit…
Proteasome activator PA200 maintains stability of histone marks during transcription and aging.
Proteasome activator PA200 regulates myofibroblast differentiation.
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Two Chemotherapy Regimens Plus or Minus Bevacizumab
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
Ph I SU011248 + Irinotecan in Treatment of Pts w MG
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ